InsidersTradesSigma
Explore the complete record of transactions filed by Amin Dipti, Director. Officer active across 1 company, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €52k. Activity tracked since 28 March 2022. The latest transaction was disclosed on 28 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Amin Dipti is a Director of Lineage Cell Therapeutics, Inc. In this role, she participates in the governance of the company and in strategic decision-making. Her expertise in the biotechnology field helps to guide the company's policies.